目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. Therapeutic Area
1.1.3. End - user
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Volume price analysis (Model 2)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4

Chapter 2. Executive Summary
2.1. Market Outlook

Chapter 3. Plasmid DNA Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing disease prevalence
3.2.1.2. Growing Investments in Research Studies
3.2.1.3. Growing Popularity of Gene Therapy
3.2.2. Market restraint analysis
3.2.2.1. Lack of advanced infrastructure for manufacturing in certain developing countries
3.2.2.2. Quality Issues associated with Contract Manufacturing
3.2.3. Covid - 19 Impact & Recovery Analysis
3.2.4. Heat Map Analysis
3.2.5. Major Deals and Strategic Alliances Analysis
3.2.6. Industry Analysis - Porter’s
3.2.7. PESTLE Analysis

Chapter 4. Plasmid DNA Contract Manufacturing Market: Application Segment Analysis
4.1. Plasmid DNA Contract Manufacturing Market: Definition & Scope
4.2. Plasmid DNA Contract Manufacturing Market: Application Market Share Analysis, 2022 & 2030
4.2.1. Gene Therapy
4.2.1.1. Gene Therapy Market, 2018 - 2030 (USD Million)
4.2.2. Immunotherapy
4.2.2.1. Immunotherapy Market, 2018 - 2030 (USD Million)
4.2.3. Others
4.2.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Plasmid DNA Contract Manufacturing Market: Therapeutic Area Segment Analysis
5.1. Plasmid DNA Contract Manufacturing Market: Definition & Scope
5.2. Plasmid DNA Contract Manufacturing Market: Therapeutic Area Market Share Analysis, 2022 & 2030
5.2.1. Cancer
5.2.1.1. Cancer Market, 2018 - 2030 (USD Million)
5.2.2. Infectious Diseases
5.2.2.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
5.2.3. Autoimmune Diseases
5.2.3.1. Autoimmune Diseases Market, 2018 - 2030 (USD Million)
5.2.4. Cardiovascular Diseases
5.2.4.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
5.2.5. Others
5.2.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Plasmid DNA Contract Manufacturing Market: End - user Segment Analysis
6.1. Plasmid DNA Contract Manufacturing Market: Definition & Scope
6.2. Plasmid DNA Contract Manufacturing Market: End - user Market Share Analysis, 2022 & 2030
6.2.1. Pharmaceutical and Biotechnology Companies
6.2.1.1. Pharmaceutical and Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.2.2. Research Institutes
6.2.2.1. Research Institutes Market, 2018 - 2030 (USD Million)

Chapter 7. Plasmid DNA Contract Manufacturing Market: Regional Analysis
7.1. Plasmid DNA Contract Manufacturing Market: Regional market share analysis, 2022 & 2030
7.2. North America
7.2.1. North America Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.3.2. U.K.
7.3.2.1. U.K. Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.3.4. Italy
7.3.4.1. Italy Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.3.5. Spain
7.3.5.1. Spain Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.3.6. Denmark
7.3.6.1. Denmark Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.3.7. Sweden
7.3.7.1. Sweden Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.3.8. Norway
7.3.8.1. Norway Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.3.9. Rest of EU
7.3.9.1. Rest of EU Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.4.3. India
7.4.3.1. India Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.4.4. Japan
7.4.4.1. Japan Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Australia Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Thailand Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. South Korea Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.4.8. Rest of APAC
7.4.8.1. Rest of APAC Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Mexico Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Argentina Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.5.5. Rest of LATAM
7.5.5.1. Rest of LATAM Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. South Africa Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.6.3. South Arabia
7.6.3.1. South Africa Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. UAE Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Kuwait Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)
7.6.6. Rest of MEA
7.6.6.1. Rest of MEA Plasmid DNA Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Plasmid DNA Contract Manufacturing Market: Company market share analysis, 2022 & 2030
8.2. Company Profiles
8.2.1. Lonza
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Service benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Charles River Laboratories
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Service benchmarking
8.2.2.4. Strategic initiatives
8.2.3. VGXI, Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Service benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Plasmid Factory GmbH & Co. KG
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Service benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Boehringer Ingelheim Bioxellence
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Service benchmarking
8.2.5.4. Strategic initiatives
8.2.6. BioCina
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Service benchmarking
8.2.6.4. Strategic initiatives
8.2.7. ThermoFisher Scientific Inc.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Service benchmarking
8.2.7.4. Strategic initiatives
8.2.8. VIVE Biotech
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Service benchmarking
8.2.8.4. Strategic initiatives
8.2.9. TriLink Biotechnologies
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Service benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Esco Aster Pte. Ltd
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Service benchmarking
8.2.10.4. Strategic initiatives

List of Tables
Table 1 List of Secondary sources
Table 2 List of Abbreviations

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Commodity flow analysis
Fig. 8 Volume price analysis
Fig. 9 Plasmid DNA Contract Manufacturing market snapshot (2022)
Fig. 10 Plasmid DNA Contract Manufacturing market segmentation
Fig. 11 Heat map analysis
Fig. 12 Parent market outlook
Fig. 13 Ancillary market outlook
Fig. 14 Market driver relevance analysis (Current & future impact)
Fig. 15 Market restraint relevance analysis (Current & future impact)
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Plasmid DNA Contract Manufacturing market Application outlook: Segment dashboard
Fig. 19 Plasmid DNA Contract Manufacturing market: Application movement analysis
Fig. 20 Cell & Gene Therapy market, 2018 - 2030 (USD Million)
Fig. 21 Immunotherapy market, 2018 - 2030 (USD Million)
Fig. 22 Others market, 2018 - 2030 (USD Million)
Fig. 23 Plasmid DNA Contract Manufacturing market Therapeutic Area outlook: Segment dashboard
Fig. 24 Plasmid DNA Contract Manufacturing market: Therapeutic Area movement analysis
Fig. 25 Cancer market, 2018 - 2030 (USD Million)
Fig. 26 Infectious Diseases market, 2018 - 2030 (USD Million)
Fig. 27 Autoimmune Diseases market, 2018 - 2030 (USD Million)
Fig. 28 Cardiovascular Diseases market, 2018 - 2030 (USD Million)
Fig. 29 Others market, 2018 - 2030 (USD Million)
Fig. 30 Plasmid DNA Contract Manufacturing market End-user outlook: Segment dashboard
Fig. 31 Plasmid DNA Contract Manufacturing market: End-user movement analysis
Fig. 32 Pharmaceutical and Biotechnology Companies market, 2018 - 2030 (USD Million)
Fig. 33 Research Institutes market, 2018 - 2030 (USD Million)
Fig. 34 Regional market: Key takeaways
Fig. 35 Plasmid DNA Contract Manufacturing market: Regional movement analysis
Fig. 36 North America. market, 2018 - 2030 (USD Million)
Fig. 37 U.S. market, 2018 - 2030 (USD Million)
Fig. 38 Canada market, 2018 - 2030 (USD Million)
Fig. 39 Europe market, 2018 - 2030 (USD Million)
Fig. 40 UK market, 2018 - 2030 (USD Million)
Fig. 41 Germany market, 2018 - 2030 (USD Million)
Fig. 42 France market, 2018 - 2030 (USD Million)
Fig. 43 Italy market, 2018 - 2030 (USD Million)
Fig. 44 Spain market, 2018 - 2030 (USD Million)
Fig. 45 Denmark market, 2018 - 2030 (USD Million)
Fig. 46 Sweden market, 2018 - 2030 (USD Million)
Fig. 47 Norway market, 2018 - 2030 (USD Million)
Fig. 48 Rest of EU market, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 50 Japan market, 2018 - 2030 (USD Million)
Fig. 51 China market, 2018 - 2030 (USD Million)
Fig. 52 India market, 2018 - 2030 (USD Million)
Fig. 53 Australia market, 2018 - 2030 (USD Million)
Fig. 54 Thailand market, 2018 - 2030 (USD Million)
Fig. 55 South Korea market, 2018 - 2030 (USD Million)
Fig. 56 Rest of APAC market, 2018 - 2030 (USD Million)
Fig. 57 Latin America market, 2018 - 2030 (USD Million)
Fig. 58 Brazil market, 2018 - 2030 (USD Million)
Fig. 59 Mexico market, 2018 - 2030 (USD Million)
Fig. 60 Argentina market, 2018 - 2030 (USD Million)
Fig. 61 Rest of LATAM market, 2018 - 2030 (USD Million)
Fig. 62 MEA market, 2018 - 2030 (USD Million)
Fig. 63 South Africa market, 2018 - 2030 (USD Million)
Fig. 64 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 65 UAE market, 2018 - 2030 (USD Million)
Fig. 66 Kuwait market, 2018 - 2030 (USD Million)
Fig. 67 Rest of MEA market, 2018 - 2030 (USD Million)